Indaptus Therapeutics, Inc. (INDP)
1.17
+0.04
(+3.54%)
USD |
NASDAQ |
Sep 02, 16:00
1.15
-0.02
(-1.71%)
After-Hours: 20:00
Indaptus Therapeutics Net Income (Quarterly) : -1.795M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.795M |
| March 31, 2026 | -2.541M |
| December 31, 2025 | -8.112M |
| September 30, 2025 | -2.975M |
| June 30, 2025 | -5.229M |
| March 31, 2025 | -4.532M |
| December 31, 2024 | -4.131M |
| September 30, 2024 | -3.069M |
| June 30, 2024 | -4.015M |
| March 31, 2024 | -3.807M |
| December 31, 2023 | -4.003M |
| September 30, 2023 | -3.922M |
| June 30, 2023 | -3.245M |
| March 31, 2023 | -4.253M |
| December 31, 2022 | -3.656M |
| September 30, 2022 | -3.466M |
| June 30, 2022 | -3.836M |
| March 31, 2022 | -3.365M |
| December 31, 2021 | -3.216M |
| September 30, 2021 | -3.367M |
| June 30, 2021 | -0.5155M |
| March 31, 2021 | -0.6124M |
| December 31, 2020 | -0.7702M |
| September 30, 2020 | -1.543M |
| June 30, 2020 | -2.947M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.87M |
| December 31, 2019 | -6.556M |
| September 30, 2019 | -20.38M |
| June 30, 2019 | -10.01M |
| March 31, 2019 | -10.66M |
| December 31, 2018 | -12.60M |
| September 30, 2018 | -9.178M |
| June 30, 2018 | -11.03M |
| March 31, 2018 | -10.73M |
| December 31, 2017 | -10.24M |
| September 30, 2017 | -7.652M |
| June 30, 2017 | -6.521M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -2.984M |
| September 30, 2015 | -1.398M |
| June 30, 2015 | -0.8829M |
| March 31, 2015 | -1.905M |
| December 31, 2014 | -1.548M |
| September 30, 2014 | -1.428M |
| June 30, 2014 | -1.323M |
| March 31, 2014 | -1.384M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 39.39M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.795M |
| EPS Diluted (Quarterly) | -0.0155 |
| Enterprise Value | 144.34M |
| Earnings Yield | -596.1% |
| Normalized Earnings Yield | -571.91 |